Body mass index and the prevalence of high-risk colorectal adenomas in a population undergoing screening colonoscopy in Alberta, Canada

Cancer Causes Control. 2024 Dec;35(12):1525-1529. doi: 10.1007/s10552-024-01914-z. Epub 2024 Aug 30.

Abstract

Purpose: There is limited evidence regarding body mass index (BMI) as an early marker of high-risk adenoma (HRA) at the time of screening colonoscopy. Because high-risk adenomas (HRA) can develop into colorectal cancer (CRC), BMI could serve as an important clinical predictor of future risk of CRC.

Methods: We examined data from 1831 adults undergoing screening colonoscopy at the Forzani & MacPhail Colon Cancer Screening Center in Alberta, Canada. We fit multivariable logistic regression models to examine the association between BMI and HRA. Non-linear relationships for BMI on HRA were also evaluated using restricted cubic splines.

Results: The mean BMI in patients with HRA was 28.2 kg/m2 compared to 27.4 kg/m2 in patients without adenomas (t test: p = 0.003). In the adjusted models, those with a BMI over 30 kg/m2 had 1.45 (95% CI 1.05-2.00) times the odds of HRA detected during colonoscopy compared to those with a BMI below 25 kg/m2. Examining BMI as continuous, the odds of HRA were 1.20 (95% CI 1.04-1.37) times higher for every 5 kg/m2 increase in BMI.

Conclusion: The findings of this study suggest that excess body mass is associated with higher risk of HRA among a screening population and may be useful an early marker of future disease.

Keywords: Body mass index; Colorectal neoplasms; Early detection of cancer; Logistic models; Risk factors.

MeSH terms

  • Adenoma* / diagnosis
  • Adenoma* / epidemiology
  • Adult
  • Aged
  • Alberta / epidemiology
  • Body Mass Index*
  • Colonoscopy* / statistics & numerical data
  • Colorectal Neoplasms* / diagnosis
  • Colorectal Neoplasms* / epidemiology
  • Early Detection of Cancer* / statistics & numerical data
  • Female
  • Humans
  • Male
  • Mass Screening / methods
  • Middle Aged
  • Prevalence
  • Risk Factors